Results 41 to 50 of about 28,789 (229)

Severe visual impairment due to an optic neuropathy and central retinal vein occlusion in a sarcoidosis patient

Journal of Ophthalmic Inflammation and Infection, 2020
Background The ophthalmic manifestation of neurosarcoidosis is varied. The complication of optic neuropathy and central retinal vein occlusion (CRVO) is rare in sarcoidosis.
Miki Hiraoka
doaj   +1 more source

Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins [PDF]

, 2010
A retinal vein occlusion (RVO) is a sight threatening disease. It can be divided into central vein occlusion and branch retinal vein occlusion. The pathogenesis of the condition remains to be solved.
T Leber von, SS Hayreh, MC Ennema, Y Koyanagi, J Zhao, JS Duker, G Staurenghi, D Weinberg, NL Christoffersen, BA Klien, RD Sperduto, R Avci, T Kube, K Kumagai, GT Frangieh, R Seitz, IM Rabinowicz, SS Hayreh, E Baglivo, P Jefferies, A Greenwood, Y Koyanagi, B Kumar, H Noma, J Messerli, T Haufschild, G Hollo, A Iannaccone, N Cheung, R Klein, P Mitchell, DH Orth, H Noma, F Badala, SS Hayreh, DJ Browning, G Ducos de Lahitte, MC Janssen, PL Ludmer, KB Swedberg, N Pellanda, MW MacCumber, DT Connolly, J Flammer, B Teuchner, K Takei, A Lerman, SJ An, AP Adamis, C Kaur, JS Penn, DV Faller, RS Clemett, S Orgul, A Gass, A Ergul, E Stefansson, B Sonnsjo, G Tezel, HJ Kaiser, PL Lip, SP Park, T Cumurcu, J Garci-Arumi, J Rader, O Arend, MC Grieshaber, SJ Rankin, MC Grieshaber, YC Yoo, WH Morgan, JB Jonas, J Flammer, G Leroux Les Jardins, DS Mojon, G Prasanna, S Saarelainen, JW Weiss, P Gasser, K Gugleta, M Mozaffarieh, N Koseki   +81 more
core   +1 more source

Long-term management of non-ischemic central retinal vein occlusion with fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®)

Therapeutic Advances in Ophthalmology, 2019
Introduction: Macular edema after central retinal vein occlusion is a common cause of vision loss. Upregulation of vascular endothelial growth factor and higher levels of inflammatory mediators have been involved in the pathogeny of the macular edema in ...
João Coelho, Bernardete Pessoa, Angelina Meireles   +2 more
doaj   +1 more source

ROLE OF BEVACIZUMAB FOR PREVENTION OF NEOVASCULAR GLAUCOMA IN ACUTE RETINAL VEIN OCCLUSION [PDF]

Journal of University Medical & Dental College, 2018
: There is a possibility of developing neovascular glaucoma in ischemic type of retinal vein occlusion. Purpose of the study is to determine the role of anti VEGF agent bevacizumab for prevention of neovascular glaucoma in ischemic type of retinal vein ...
Bassam Mubarik , Adeen Akram
doaj   +1 more source

Treating macular edema following RVO [PDF]

, 2014
Retinal vein occlusion (RVO) affects 16 million people worldwide, usually the middle-aged or older. It is caused by thrombosis, the clogging of the retinal veins, which may occur in the four branch veins – branch vein retinal occlusion (BVRO), or in the ...
Hrytsay, T.
core  

Integrated results from the COPERNICUS and GALILEO studies. [PDF]

, 2017
OBJECTIVES: To report on the efficacy and safety of intravitreal aflibercept in patients with macular edema secondary to central retinal vein occlusion (CRVO) in an integrated analysis of COPERNICUS and GALILEO.
Ahlers, Christiane, Asmus, Friedrich, Boyer, David S., Clark, W. Lloyd, Haller, Julia A., Holz, Frank G., Korobelnik, Jean-Francois, Ogura, Yuichiro, Pielen, Amelie, Rittenhouse, Kay D., Saroj, Namrata, Stemper, Brigitte, Vitti, Robert, Zeitz, Oliver   +13 more
core   +3 more sources

Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction

Advanced Healthcare Materials, EarlyView.
Atherosclerosis management is hindered by poor drug targeting and plaque heterogeneity. Nanotechnology overcomes these barriers via three core strategies: (1) target‐engineered nanocarriers that achieve lesion‐specific precision via ligand modification, biomimetic camouflage, stimuli‐responsive release, and self‐propelling nanomotors; (2) catalytic ...
Yuqi Yang, Jingguo Qu, Tonghuan Xiao, Xinyang Han, Michael Tin‐Cheung Ying   +4 more
wiley   +1 more source

Acute Central Retinal Vein Occlusion Secondary to Reactive Thrombocytosis after Splenectomy

Case Reports in Ophthalmological Medicine, 2014
The diagnosis and treatment of central retinal vein occlusion was reported in a young patient. Central retinal vein occlusion was probably related to secondary to reactive thrombocytosis after splenectomy.
Nursen Oncel Acir, Mehmet Borazan, Zeynep Dadaci   +2 more
doaj   +1 more source

Retinal vascular occlusion in patients with the Covid-19 virus

International Journal of Retina and Vitreous, 2022
Background The coronavirus disease (COVID-19) can cause acute respiratory distress syndrome with dyspnea, anosmia, fever, and cough. Few studies describing ocular findings have been reported.
Helio F. Shiroma, Luiz H. Lima, Yuri B. Shiroma, Tereza C. Kanadani, Mario J. Nobrega, Gabriel Andrade, Milton Nunes de Moraes Filho, Fernando M. Penha   +7 more
doaj   +1 more source

Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion [PDF]

, 2016
No abstract ...
Abdolrahimzadeh, Solmaz, Plateroti, ANDREA MARIA, Plateroti, Pasquale, Scarinci, Fabio   +3 more
core   +1 more source